AFJK Valuation Metrics
FCF$-672289.00
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
Aimei Health Technology Co Ltd
Exchange: NASDAQSector: IndustrialsIndustry: Shell Companies
Aimei Health Technology Co Ltd
Did you know?
Carries 8.1x more debt than cash on its balance sheet.
Current Price
$46.18
+5.68%Profile
Valuation (TTM)
Market Cap$282.70M
P/E201.10
EV—
P/B—
Shares Out6.12M
P/Sales—
Revenue$0.00
EV/EBITDA202.28
Aimei Health Technology Co Ltd (AFJK) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →AFJK Valuation & Fair Value Analysis
Aimei Health Technology Co Ltd (AFJK) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is 201.10. Enterprise value to EBITDA is 202.28. PEG ratio is -8.04.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Aimei Health Technology Co Ltd's intrinsic value.